David Zhang


  • JD, The George Washington University Law School, 2009
  • BA (Psychology), summa cum laude, The George Washington University, 2005; Presidential Academic Scholarship Award 2002-2005


  • Hong Kong, Registered Foreign Lawyer (New York)
  • New York, 2010
  • Chinese (Mandarin)

David Zhang


View the Chinese version.

David Zhang is a partner of Ropes & Gray LLP, and is currently on assignment in Hong Kong as a Senior Foreign Legal Consultant. His practice concentrates on advising clients on internal investigations, due diligence, and compliance programs, particularly with a focus on anti-corruption and anti-bribery matters in China.

David has represented and conducted internal investigations for multinational and U.S.-listed clients across different industries, including pharmaceutical, medical device, internet and technology, hotel and hospitality, venture capital/private equity and aerospace and aviation. David is natively bilingual in English and Mandarin Chinese, and he has extensive cultural knowledge of the China region.


  • Conducted numerous internal investigations related to anti-corruption, off- label promotion, clinical studies, bid-rigging and export compliance for multinational life sciences companies, including Fortune 100 corporations.  
  • Conducted an anti-corruption internal investigation for U.S.-listed leading provider of cloud computing services in one of its international markets, including advising the client on self-disclosure to U.S. DOJ and SEC. 
  • Conducted internal investigations regarding anti-corruption and revenue recognition issues for U.S.-listed industrial equipment manufacturer.  
  • Conducted internal investigations regarding procurement fraud, conflict of interest and embezzlement for U.S.-headquartered company with manufacturing operations in China.
  • Conducted an anti-corruption internal investigation for U.S.-listed and privately-held companies across different industries, including hotel management, food & beverage and manufacturing.  
  • Advised multi-national medical device company regarding its government-appointed compliance monitorship.
  • Conducted a number of comprehensive compliance risk assessment and post-acquisition due diligence of multinational life sciences companies’ local subsidiaries and operations.
  • Advised life sciences companies, international venture capital and private equity funds on various anti-corruption and trade compliance due diligence for investments in Asia.
  • Conducted anti-corruption training in Mandarin and English for local employees of multinational corporations and portfolio companies of international investment funds.
  • Advised clients on developing and implementing anti-corruption compliance policies and procedures, channel and third-party risk management measures, and internal monitoring and control mechanisms for local operations of multinational corporations.
  • Previously seconded to a Fortune 50 pharmaceutical company to assist with compliance and internal investigation matters.



  • Speaker, “Tackling Compliance Issues: Creating a Compliance Culture and Recent US Enforcement Trends,” Japan In-House Counsel Network (JICN) Event with Ropes & Gray in Tokyo (March 2019)
  • Moderator, “Leveraging Data and Behavioral Sciences In Legal Risk Management,” Ropes & Gray Risk Management Roundtable, Hong Kong (January 2019) 
  • Keynote speaker, “2019 Bribery and Corruption Outlook - Case Studies and Recent Enforcement Trends”; and moderator, “Tone from the Top – What Does It Mean and Experiences in Execution?” European Chamber of Commerce Annual Compliance Conference, Shanghai (September 2018) 
  • Panelist, “The FCPA Pilot Program and considerations in evaluating voluntary self-disclosure” Ropes & Gray Medical Device Roundtable (May 2017)
  • Panelist, “FCPA Pilot Program: The Value of Self-disclosure” Ropes & Gray Roundtable in conjunction with Chambers, Shanghai (May 2017)
  • Speaker, “Differences between the FCPA and PRC Law: Compliance Traps Posed by Distributors Under Different Laws” Everpro Law Seminar on Distributor Compliance (March 2017)
Cookie Settings